Results 21 to 30 of about 22,609,963 (202)

Redox control of β2‐glycoprotein I–von Willebrand factor interaction by thioredoxin‐1 [PDF]

Journal of Thrombosis and Haemostasis, 2010
 β(2) -Glycoprotein I (β(2) GPI) is an abundant plasma protein that is closely linked to blood clotting, as it interacts with various protein and cellular components of the coagulation system. However, the role of β(2) GPI in thrombus formation is unknown.
Passam, F, Rahgozar, S, Qi, M, Raftery, MJ, Wong, JWH, Tanaka, K, Ioannou, Y, Zhang, JY, Gemmell, R, Qi, JC, Giannakopoulos, B, Hughes, WE, Hogg, PJ, Krilis, S, Qi, Jian   +14 more
openaire   +4 more sources

The certification of the concentration of anti-β2-glycoprotein I IgG in human serum: ERM®-DA477/IFCC [PDF]

, 2022
This report describes the production of ERM-DA477/IFCC, which is a matrix material certified for the concentration of anti-β2 glycoprotein I IgG (anti-β2GPI IgG) in human serum.
MARTOS Gustavo, DEPREZ Liesbet, MONOGIOUDI Evanthia, TRAPMANN Stefanie, ZEGERS Ingrid   +4 more
core   +1 more source

Antiphospholipid Antibody Assays in 2021: Looking for a Predictive Value in Addition to a Diagnostic One

Frontiers in Immunology, 2021
Antiphospholipid antibodies (aPL) are mandatory for the diagnosis but are also a risk factor for the antiphospholipid syndrome (APS) clinical manifestations.
Pier Luigi Meroni, Maria Orietta Borghi, Maria Orietta Borghi   +2 more
doaj   +1 more source

The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis

Journal of Lipid Research, 2007
C-reactive protein (CRP) is one of the strongest independent predictors of cardiovascular disease. We have previously reported that oxidized LDL (oxLDL) interacts with β2-glycoprotein I (β2GPI), implicating oxLDL/β2GPI complexes as putative autoantigens ...
Masako Tabuchi, Katsumi Inoue, Hitomi Usui-Kataoka, Kazuko Kobayashi, Misako Teramoto, Koji Takasugi, Kenichi Shikata, Masahiro Yamamura, Kenji Ando, Keiichiro Nishida, Junko Kasahara, Noriaki Kume, Luis R. Lopez, Kazuaki Mitsudo, Masakiyo Nobuyoshi, Tatsuji Yasuda, Toru Kita, Hirofumi Makino, Eiji Matsuura   +18 more
doaj   +1 more source

Gastrointestinal symptoms as the first manifestation of antiphospholipid syndrome

BMC Gastroenterology, 2021
Background Antiphospholipid syndrome (APS) is an acquired pre-thrombotic autoimmune condition, which produces autoantibodies called antiphospholipid antibodies (APL) against phospholipid-binding plasma proteins. The diagnosis of APS requires at least one
Xiaojuan Zou, Zhongqi Fan, Ling Zhao, Weiling Xu, Jin Zhang, Zhenyu Jiang   +5 more
doaj   +1 more source

Overview of antiphospholipid antibodies (aPL) and pair-wise statistical testing (AnV, annexin 5; β2, β2-glycoprotein I, IQR, interquartile range; CL, OD, optical density; PA, phosphatidic acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine; PT, prothrombin).

, 2021
Overview of antiphospholipid antibodies (aPL) and pair-wise statistical testing (AnV, annexin 5; β2, β2-glycoprotein I, IQR, interquartile range; CL, OD, optical density; PA, phosphatidic acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG ...
Martin F. Sprinzl (4339777), Vishalini Emmenegger (11790839), Adriano Aguzzi (49294), Marc Emmenegger (11614492), Laura Rose (749727), Karl J. Lackner (7404842), Clemens J. Sommer (11790845), Dirk Roggenbuck (407723), Sreedhar Saseendran Kumar (11790836), Peter Schierack (355803), Tomas Malinauskas (10040777), Thomas Buettner (11790842), Katrin B. M. Frauenknecht (11790848)   +12 more
core   +1 more source

ω-Carboxyl variants of 7-ketocholesteryl esters are ligands for β2-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophages

Journal of Lipid Research, 2002
β2-Glycoprotein I (β2-GPI) is a major antigen for anticardiolipin antibodies (aCL, Abs) present in patients with antiphospholipid syndrome. We recently reported that β2-GPI specifically binds to oxidized LDL (oxLDL) and that the β2-GPI's major ligand ...
Qingping Liu, Kazuko Kobayashi, Jun-ichi Furukawa, Junko Inagaki, Nobuo Sakairi, Akimasa Iwado, Tatsuji Yasuda, Takao Koike, Dennis R. Voelker, Eiji Matsuura   +9 more
doaj   +1 more source

The role of platelets in antiphospholipid syndrome

Platelets, 2017
Despite extensive research, the pathogenesis of antiphospholipid syndrome (APS) remains obscure in many aspects. However, it is widely accepted that thrombosis is the result of a hypercoagulable state caused by antibodies directed against β2-glycoprotein
G. Baroni, A. Banzato, E. Bison, G. Denas, G. Zoppellaro, V. Pengo   +5 more
doaj   +1 more source

Additional file 2: of Association of anticardiolipin, antiphosphatidylserine, anti-β2 glycoprotein I, and antiphosphatidylcholine autoantibodies with canine immune thrombocytopenia

, 2016
Antiplatelet antibodies measurement. (PDF 99 kb)
Chen, Yu-Chen, Lang-Ming Chi, Kuan-Chih Chow, Shiow-Her Chiou, Fan, Yi-Hsin, Ho, Shu-Peng, Hsu, Yu-Chen, Yu-Chyi Hwang, Meng-Xing Wu, Lee, Wei-Ming, Shiun-Long Lin, Chau-Loong Tsang, Mao, Frank   +12 more
openaire   +1 more source

Correlation Between Serum β2-GPI/oxLDL and the Risk of Cerebral Infarction in Patients with T2DM

Frontiers in Surgery, 2022
ObjectiveThis study aims to study the correlation between serum β2-glycoprotein I (β2-GPI)/oxidized low-density lipoprotein (oxLDL) and the risk of cerebral infarction in patients with type 2 diabetes (T2DM).MethodsFrom January 2019 to March 2021, 56 ...
Wending Kuang, Yi Li, Gang Liu, Yang Zhang, Gang Chen, Bang Luo, Shuangyu Kuang   +6 more
doaj   +1 more source